Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Pharmaceutical Preparations
Latest Price
$8.97
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
6.75
P/B Ratio
1.33
Institutional Ownership
69.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 2.34M | $22.0M | 13.22% | -- | 2026-03-31 |
| ORBIMED ADVISORS LLC | 1.74M | $16.0M | 9.79% | +140.0K | 2026-03-31 |
| Aberdeen Group plc | 1.32M | $12.0M | 7.45% | -- | 2026-03-31 |
| CITADEL ADVISORS LLC | 806.6K | $7.0M | 4.55% | -93.1K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 734.1K | $6.0M | 4.14% | -- | 2026-03-31 |
| Prosight Management, LP | 697.1K | $6.0M | 3.93% | +13.2K | 2026-03-31 |
| DIADEMA PARTNERS LP | 555.3K | $5.0M | 3.13% | -- | 2026-03-31 |
| Stonepine Capital Management, LLC | 383.5K | $3.0M | 2.16% | -6.5K | 2026-03-31 |
| ADAR1 Capital Management, LLC | 366.8K | $3.0M | 2.07% | +80.0K | 2026-03-31 |
| ARMISTICE CAPITAL, LLC | 364.0K | $3.0M | 2.05% | -172.0K | 2026-03-31 |